Grady H. Hendrix

TL;DR: The findings indicate that despite its beneficial hemodynamic actions, long-term therapy with oral milrinone increases the morbidity and mortality of patients with severe chronic heart failure.

TL;DR: Six months of therapy with 60 mg of vesnarinone per day resulted in lower morbidity and mortality and improved the quality of life of patients with congestive heart failure, however, a higher dose of veNarinone (120 mg per day) increased mortality, suggesting that this drug has a narrow therapeutic range.

TL;DR: The results indicate that preoperative ventricular function is still an important determinant of outcome of aortic valve replacement for aorta regurgitation, however, current medical and surgical techniques permit a better prognosis in the presence of reduced ventricularfunction than was previously considered possible.

TL;DR: The SF-36 was better able to differentiate physical and emotional aspects of QOL in this sample and the LHFQ subscales may be less useful in QOL assessment than the total score.

TL;DR: The presence of silent myocardial ischemia identified during exercise stress thallium testing is of prognostic value, independent of angiographic variables such as extent of CAD and left ventricular ejection fraction.